MM treated/mock-treated cells were first examined by Western blot and flow cytometry to determine the Heca452 and PSGL-1 expression levels on the cell surface and then tested in a rolling assay on E- and P-selectin. The gene discussed is SELP; the disease is Miyoshi myopathy.